Clindamycin
Treatment for Diphtheria
Typical Dosage: 300-450 mg orally TID/QID or IV
Effectiveness
90%
Safety Score
70%
Clinical Trials
20
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanideâ ī¸
Methđ
CigarettesđŦ
Chemoâĸī¸
Alcoholđē
Morphineđ
Antibioticsđ
Tylenolđ
Exerciseđ
Waterđ§
70
DangerousModerateSafe
Treatment Details
Dosage Range
300-450 mg orally TID/QID or IV
Time to Effect
24-48 hours
Treatment Duration
14 days
Evidence Quality
MODERATENumber Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$100
Side Effect Mgmt:$400
Total Annual:$600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$667
Cost per Remission
$667
Prescription Access Economics
Physician Visit Cost
$125/year
Time Cost
$35/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$100/year
Potential OTC Price
$50/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATEMissed Diagnosis Risk
HIGHClindamycin Outcomes
for Diphtheria
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+90%
Common Side Effects
Diarrhea
+15%
Clostridioides difficile infection
+5%
Nausea/Vomiting
+8%
Rash
+2%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov